Literature DB >> 7589460

Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the delta- and mu-opioid receptors.

K Fukuda1, K Terasako, S Kato, K Mori.   

Abstract

Effects of amino acid substitutions in the first extracellular loop region of the delta- and mu-opioid receptors were examined. Substitution of lysine-108 of the delta-receptor (delta K108) with asparagine improved affinity to [D-Ala2,MePhe4,Gly-ol5]enk ephalin (DAGO), a mu-selective peptide agonist, to be comparable with that of the mu-receptor. On the other hand, replacement of mN127 with lysine decreased the affinity to DAGO by approximately 15-fold. These results suggest that dK108 and mN127, which correspond to each other in the aligned amino acid sequences, mainly determine the difference in DAGO binding affinity between the delta- and mu-receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589460     DOI: 10.1016/0014-5793(95)01034-c

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Molecular modeling study of the differential ligand-receptor interaction at the mu, delta and kappa opioid receptors.

Authors:  M Filizola; M Carteni-Farina; J J Perez
Journal:  J Comput Aided Mol Des       Date:  1999-07       Impact factor: 3.686

Review 2.  Homology modeling of opioid receptor-ligand complexes using experimental constraints.

Authors:  Irina D Pogozheva; Magdalena J Przydzial; Henry I Mosberg
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 3.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 4.  Mode matches and their locations in the hydrophobic free energy sequences of peptide ligands and their receptor eigenfunctions.

Authors:  A J Mandell; K A Selz; M F Shlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  The role of the hydrophilic Asn230 residue of the mu-opioid receptor in the potency of various opioid agonists.

Authors:  J Pil; J Tytgat
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

6.  Modulation of the Interaction between a Peptide Ligand and a G Protein-Coupled Receptor by Halogen Atoms.

Authors:  Mònica Rosa; Gianluigi Caltabiano; Katy Barreto-Valer; Verónica Gonzalez-Nunez; José C Gómez-Tamayo; Ana Ardá; Jesús Jiménez-Barbero; Leonardo Pardo; Raquel E Rodríguez; Gemma Arsequell; Gregorio Valencia
Journal:  ACS Med Chem Lett       Date:  2015-07-16       Impact factor: 4.345

7.  A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.

Authors:  Chris M Brasel; Gregory W Sawyer; Craig W Stevens
Journal:  Eur J Pharmacol       Date:  2008-10-09       Impact factor: 4.432

8.  Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.

Authors:  I D Pogozheva; A L Lomize; H I Mosberg
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

Review 9.  Generic GPCR residue numbers - aligning topology maps while minding the gaps.

Authors:  Vignir Isberg; Chris de Graaf; Andrea Bortolato; Vadim Cherezov; Vsevolod Katritch; Fiona H Marshall; Stefan Mordalski; Jean-Philippe Pin; Raymond C Stevens; Gerrit Vriend; David E Gloriam
Journal:  Trends Pharmacol Sci       Date:  2014-12-22       Impact factor: 14.819

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.